ClearPoint Neuro, Inc. (CLPT) News
Filter CLPT News Items
CLPT News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
Latest CLPT News From Around the Web
Below are the latest news stories about ClearPoint Neuro Inc that investors may wish to consider to help them evaluate CLPT as an investment opportunity.
ClearPoint Neuro: Underlying Growth Potential Concealed By COVIDThis article is contributed by Jun Hao from our Superstocks Seekers team. [To receive real-time notifications of our latest updates/articles, click the "Follow" button on the left of your screen.] Overview ClearPoint Neuro (CLPT) is a neurological platform company that allows neurosurgeons to perform minimally invasive procedures for the most... |
Adirondack Trust Co Buys Vanguard Russell 2000 Index Fund, Ford Motor Co, Arco Platform, Sells ...Saratoga Springs, NY, based Investment company Adirondack Trust Co (Current Portfolio) buys Vanguard Russell 2000 Index Fund, Ford Motor Co, Arco Platform, Kiniksa Pharmaceuticals, TransMedics Group Inc, sells Vanguard Russell 3000 Index Fund, Vanguard Total International Stock, AT&T Inc, Eli Lilly and Co, Vanguard FTSE Developed Markets ETF during the 3-months ended 2021Q4, according to the most recent filings of the investment company, Adirondack Trust Co. |
ClearPoint Neuro to Participate at the H.C. Wainwright BIOCONNECT Virtual ConferenceSOLANA BEACH, Calif., Jan. 05, 2022 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the brain, announced today that its management will participate at the H.C. Wainwright BIOCONNECT Virtual Conference. A pre-recorded company presentation will be available on the conference website beginning at 7 a.m. ET / 4 a.m. PT on January 10, 2022. About ClearPoint Neuro ClearPoint Neuro’s mission is to |
Royce Value Trust, Inc. Buys Calix Inc, MaxCyte Inc, Dutch Bros Inc, Sells EQT Corp, ...Investment company Royce Value Trust, Inc. (Current Portfolio) buys Calix Inc, MaxCyte Inc, Dutch Bros Inc, Eagle Materials Inc, Scientific Games Corp, sells EQT Corp, SmileDirectClub Inc, , Hilton Grand Vacations Inc, Kulicke & Soffa Industries Inc during the 3-months ended 2021Q3, according to the most recent filings of the investment company, Royce Value Trust, Inc.. |
ClearPoint Neuro (NASDAQ:CLPT) shareholders are still up 635% over 3 years despite pulling back 13% in the past weekIt might be of some concern to shareholders to see the ClearPoint Neuro, Inc. ( NASDAQ:CLPT ) share price down 20% in... |
ClearPoint Neuro Congratulates Blackrock Neurotech on Receiving Breakthrough Device Designation from the FDA for the MoveAgain Brain-Computer Interface SystemSOLANA BEACH, Calif., Nov. 17, 2021 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the brain, today congratulates partner Blackrock Neurotech for receiving Breakthrough Device designation from the U.S. Food and Drug Administration (FDA) for its groundbreaking MoveAgain Brain Computer Interface (BCI) system. There are an estimated 5.35 million1 people in the United States who suffer from pa |
ClearPoint Neuro Reports Third Quarter 2021 ResultsRecord Revenue Achieved; Company Reaffirms 2021 Revenue ForecastSOLANA BEACH, Calif., Nov. 09, 2021 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the brain, today announced financial results for its third quarter ended September 30, 2021. Third Quarter Highlights Reported record revenue of $4.6 million, a 30% year-over-year increase;Increased biologics and drug delivery revenue to $2.1 mi |
ClearPoint Neuro Congratulates Neurona Therapeutics on IND Clearance for Neural Cell Therapy NRTX-1001 in Chronic Focal Epilepsy PatientsSOLANA BEACH, Calif., Nov. 08, 2021 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the brain, today congratulates partner Neurona Therapeutics on clearance by the U.S. Food and Drug Administration (FDA) of its Investigational New Drug (IND) application to initiate its first-in-human Phase 1/2 clinical trial evaluating the safety and efficacy of NRTX-1001 in patients with drug-resistant mes |
ClearPoint Neuro to Present at the 2021 Stifel Virtual Healthcare ConferenceSOLANA BEACH, Calif., Nov. 04, 2021 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the brain, announced today that its management will present at the 2021 Stifel Virtual Healthcare Conference on Tuesday, November 16, 2021 at 10:40 a.m. Eastern Time via invite only. Registration is available by contacting [email protected] An online archive of the broadcast will be available |
Internationally Renowned Neurosurgeon and Accomplished Researcher Dr. Linda M. Liau Joins ClearPoint Neuro Board of DirectorsSOLANA BEACH, Calif., Nov. 02, 2021 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the brain, is pleased to announce that Linda M. Liau, MD, PhD, MBA, has been appointed to the Company’s Board of Directors effective immediately. Dr. Linda M. Liau is Professor and W. Eugene Stern Chair of the Department of Neurosurgery at the David Geffen School of Medicine at UCLA. She is the Co-Director o |